Structure Therapeutics Ownership | Who Owns Structure Therapeutics?
Structure Therapeutics Ownership Summary
Structure Therapeutics is owned by 94.89% institutional investors, 3.07% insiders, and 2.04% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 8.92% of GPCR shares.
GPCR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Structure Therapeutics | 94.89% | 3.07% | 2.04% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Deep track capital, lp | 5.13M | 8.92% | $106.48M |
| Baker bros. advisors lp | 2.51M | 4.36% | $52.03M |
| Bvf inc/il | 1.77M | 3.08% | $36.74M |
| Capital investors | 1.62M | 2.81% | $33.58M |
| Ra capital management | 1.52M | 2.64% | $31.47M |
| Casdin capital | 1.23M | 2.13% | $25.41M |
| Vestal point capital, lp | 1.20M | 2.09% | $24.89M |
| Orbimed advisors | 1.20M | 2.08% | $24.87M |
| Rock springs capital management lp | 1.14M | 1.97% | $23.56M |
| Tcg crossover management | 1.06M | 1.85% | $22.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Deep track capital, lp | 5.13M | 3.41% | $106.48M |
| Monashee investment management | 430.00K | 3.23% | $8.92M |
| Tcg crossover management | 1.06M | 2.52% | $22.05M |
| Foresite capital management vi | 210.00K | 2.45% | $4.36M |
| Casdin capital | 1.23M | 2.31% | $25.41M |
| Logos global management lp | 850.00K | 1.95% | $17.63M |
| Rock springs capital management lp | 1.14M | 1.47% | $23.56M |
| Bvf inc/il | 1.77M | 1.31% | $36.74M |
| Vestal point capital, lp | 1.20M | 1.31% | $24.89M |
| Birchview capital, lp | 36.00K | 0.74% | $746.64K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | 2.51M | 0.50% | 2.15M |
| Deep track capital, lp | 5.13M | 3.41% | 1.03M |
| Orbimed advisors | 1.20M | 0.62% | 547.27K |
| Casdin capital | 1.23M | 2.31% | 525.00K |
| Logos global management lp | 850.00K | 1.95% | 425.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital research global investors | - | - | -2.16M |
| Fil | - | - | -1.15M |
| Driehaus capital management | 672.79K | 0.11% | -599.95K |
| Vestal point capital, lp | 1.20M | 1.31% | -588.99K |
| Blackrock funding, inc. /de | 243.33K | 0.00% | -323.17K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Canada pension plan investment board | 167.80K | 0.00% | 167.80K | $3.48M |
| Eversept partners, lp | 99.34K | 0.19% | 99.34K | $2.06M |
| Cubist systematic strategies | 54.82K | 0.01% | 54.82K | $948.87K |
| Susquehanna portfolio strategies | 39.96K | 0.02% | 39.96K | $828.77K |
| Birchview capital, lp | 36.00K | 0.74% | 36.00K | $746.64K |
Sold Out
| Holder | Change |
|---|---|
| Larson financial group | -9.00 |
| Mather group, llc. | -35.00 |
| Fairfield financial advisors | -59.00 |
| Clearstead advisors | -67.00 |
| Corecap advisors | -77.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 186 | 11.38% | 54,608,579 | -2.37% | 94 | 99.54% | 103 | 47.14% | 42 | -16.00% |
| Mar 31, 2025 | 32 | -82.32% | 17,076,259 | -71.82% | 2 | 0.20% | 11 | -88.17% | 8 | -82.98% |
| Dec 31, 2024 | 184 | 4.55% | 60,629,867 | -1.30% | 38 | 2.54% | 94 | -2.08% | 49 | 28.95% |
| Sep 30, 2024 | 176 | -9.28% | 61,427,326 | 3.62% | 38 | 21.50% | 96 | -22.58% | 38 | -2.56% |
| Jun 30, 2024 | 194 | 34.72% | 59,282,748 | 35.85% | 13 | 13.72% | 124 | 61.04% | 39 | 8.33% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 30, 2025 | FMR LLC | See Remark 1 | Sell | - |
| Feb 06, 2025 | FMR LLC | See Remark 1 | Sell | - |
| Jun 10, 2024 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Sell | - |
| Jun 03, 2024 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | - |
| Jun 03, 2024 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 1 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
GPCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools